Return to homepagePandemic Pact

Synthesis and anti-viral evaluation of hydroxychloroquine analogues

  • Funded by Agence Universitaire de la Francophonie (AUF)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2020

  • Funder

    Agence Universitaire de la Francophonie (AUF)

  • Research Location

    Algeria

  • Lead Research Institution

    Badji Mokhtar University

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Project summary The objectives of the SyChloquine project are the synthesis of new derivatives of hydroxychloroquine, their characterization, as well as their biological evaluation in the field of several pathologies, in particular as antivirals against COVID-19. Recent work has allowed an important breakthrough in the understanding of the COVID-19 disease. Our expertise is used for the synthesis of various chloroquine derivatives. Goal Make available to biologists and infectious disease specialists and virologists a series of molecules that may interfere with COVID-19 for possible development.